Best Online Semaglutide Providers Still Offering Compounded GLP-1 (May 2026)

The compounded semaglutide landscape has narrowed dramatically in 2026. Hims and Ro exited the market. Calibrate went brand-name only. But compounded semaglutide is still available through providers that partner with 503A compounding pharmacies for patient-specific prescriptions. Here are the providers still operating — ranked by price, clinical quality, and transparency.

How We Evaluated

Every provider was assessed on 5 criteria:

1. Pricing transparency — All-inclusive or hidden fees?
2. Pharmacy sourcing — Licensed 503A pharmacy with state board oversight?
3. Clinician access — Can you actually reach your prescriber?
4. Medication range — Semaglutide only, or also tirzepatide?
5. Cancellation flexibility — Month-to-month or locked contract?

#2. Henry Meds

• Price: $199–$449/month (varies by dose)
• Pros: Well-established, wide dose range, good patient portal
• Cons: Separate consultation fee ($49). Some patients report slower clinician response times. Limited tirzepatide availability.

#3. SkinnyRx / Ivím Health

• Price: $249–$499/month
• Pros: Established compounding relationships, offers combination formulations (semaglutide + B12)
• Cons: Higher starting price. Some plans require 3-month commitment. Check current availability in your state.

#4. Heally

• Price: $225–$400/month
• Pros: Quick onboarding, marketplace model connects you with local providers
• Cons: Experience varies by clinician (marketplace model). Less consistent than direct-employ models.

#5. Mochi Health

• Price: $250–$450/month
• Pros: Strong clinical protocol, detailed intake process, metabolic health focus
• Cons: Newer to market. Limited availability in some states. Wait times reported during peak demand.

Red Flags to Watch For

• No clinician evaluation required. Any provider that ships semaglutide without a medical consultation is operating illegally.
• Prices below $150/month. Legitimate compounded semaglutide from a licensed 503A pharmacy has real costs. Prices significantly below $150 suggest either diluted formulations or unverified sourcing.
• No pharmacy licensing information. Ask which pharmacy compounds the medication and verify their state board of pharmacy license.
• No ongoing clinical oversight. A prescription-and-goodbye model is medically irresponsible. Your provider should monitor your progress and adjust dosing.